Suntrust Banks’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$986K Buy
9,203
+1,424
+18% +$146K 0.01% 747
2019
Q2
$792K Buy
7,779
+724
+10% +$69.6K ﹤0.01% 841
2019
Q1
$634K Buy
7,055
+2,718
+63% +$236K ﹤0.01% 884
2018
Q4
$361K Buy
4,337
+418
+11% +$39.2K ﹤0.01% 991
2018
Q3
$423K Sell
3,919
-350
-8% -$38.4K ﹤0.01% 974
2018
Q2
$469K Buy
4,269
+103
+2% +$10.7K ﹤0.01% 940
2018
Q1
$417K Buy
4,166
+2,122
+104% +$217K ﹤0.01% 949
2017
Q4
$201K Sell
2,044
-597
-23% -$56.6K ﹤0.01% 1172
2017
Q3
$247K Buy
+2,641
New +$280K ﹤0.01% 1121
2017
Q1
Sell
-40,357
Closed -$3.71M 1310
2016
Q4
$3.71M Sell
40,357
-955
-2% -$82.3K 0.02% 351
2016
Q3
$3.5M Buy
41,312
+1,957
+5% +$164K 0.02% 374
2016
Q2
$3.2M Buy
39,355
+1,136
+3% +$86.5K 0.02% 377
2016
Q1
$2.73M Buy
38,219
+2,267
+6% +$152K 0.02% 390
2015
Q4
$2.56M Sell
35,952
-1,145
-3% -$77K 0.02% 391
2015
Q3
$2.28M Buy
37,097
+5,339
+17% +$373K 0.02% 389
2015
Q2
$2.3M Buy
31,758
+26,563
+511% +$1.96M 0.01% 399
2015
Q1
$398K Buy
5,195
+1,938
+60% +$139K ﹤0.01% 910
2014
Q4
$217K Sell
3,257
-61
-2% -$3.85K ﹤0.01% 1104
2014
Q3
$200K Sell
3,318
-4,113
-55% -$253K ﹤0.01% 1327
2014
Q2
$434K Sell
7,431
-2,304
-24% -$135K ﹤0.01% 1050
2014
Q1
$562K Sell
9,735
-165
-2% -$8.84K ﹤0.01% 1268
2013
Q4
$528K Sell
9,900
-239
-2% -$14.2K ﹤0.01% 1239
2013
Q3
$625K Sell
10,139
-96
-0.9% -$5.75K ﹤0.01% 1120
2013
Q2
$618K Buy
+10,235
New +$610K ﹤0.01% 1061

Other funds holding DGX

Suntrust Banks's DGX Position: Q3 2019 in Review

Suntrust Banks increased its Quest Diagnostics (DGX) stake by 18% in Q3 2019, buying an estimated $146K and bringing the position to 9,203 shares worth $986K. The position accounts for 0.01% of the portfolio, ranked #747.

Suntrust Banks first reported a position in DGX in Q2 2013 and has held it in 24 quarters since. The position peaked at $3.71M in Q4 2016. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Suntrust Banks held 9,203 shares of Quest Diagnostics worth $986K as of Q3 2019.
  • Suntrust Banks bought 1,424 Quest Diagnostics shares in Q3 2019, an estimated $146K.
  • Quest Diagnostics made up 0.01% of Suntrust Banks's portfolio in Q3 2019, its #747 holding.
  • Suntrust Banks first reported a position in Quest Diagnostics in Q2 2013 and has held it in 24 quarters since.
  • Suntrust Banks's Quest Diagnostics position peaked at $3.71M in Q4 2016.
  • 677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.